Your browser doesn't support javascript.
loading
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence.
Oreja-Guevara, Celia; Brownlee, Wallace; Celius, Elisabeth G; Centonze, Diego; Giovannoni, Gavin; Hodgkinson, Suzanne; Kleinschnitz, Christoph; Havrdova, Eva Kubala; Magyari, Melinda; Selchen, Daniel; Vermersch, Patrick; Wiendl, Heinz; Van Wijmeersch, Bart; Salloukh, Hashem; Yamout, Bassem.
Afiliación
  • Oreja-Guevara C; Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain; Department of Medicine, Faculty of Medicine, Universidad Complutense de Madrid, Spain.
  • Brownlee W; Queen Square MS Centre, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
  • Celius EG; Department of Neurology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Centonze D; Department of Systems Medicine, Tor Vergata University, Rome, Italy; Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy.
  • Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Hodgkinson S; Department of Neurology, Liverpool Hospital, and UNSW Sydney, New South Wales, Australia.
  • Kleinschnitz C; Department of Neurology and Center for Translational and Behavioural Neurosciences (C-TNBS), University Hospital Essen, Essen, Germany.
  • Havrdova EK; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Magyari M; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Selchen D; Division of Neurology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Vermersch P; Univ. Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France.
  • Wiendl H; Department of Neurology, Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Van Wijmeersch B; University MS Centre, Hasselt-Pelt, Hasselt University, Belgium.
  • Salloukh H; Ares Trading SA, Eysins, Switzerland (An Affiliate of Merck KGaA).
  • Yamout B; Neurology Institute, Harley Street Medical Center, Abu Dhabi, UAE; American University of Beirut, Lebanon. Electronic address: yamoutba@gmail.com.
Mult Scler Relat Disord ; 69: 104459, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36565573
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cladribina / Esclerosis Múltiple Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2023 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cladribina / Esclerosis Múltiple Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2023 Tipo del documento: Article País de afiliación: España